Physician profile
Samuel E Kolman
NPI 1174901045
$37,030.58
in general payments reported to CMS, 2019-2025
15 companies · $1,664 in 2025
The $1,664 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.44 · 2020: $202 · 2021: $17K · 2022: $15K · 2023: $3,487 · 2024: $165 · 2025: $1,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,232 · Food and Beverage: $2,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,231.64 |
| Food and Beverage | $2,084.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,557.35 | 2021-2025 | Micra, Selectsecure, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $6,356.45 | 2021-2025 | Acticor 7 Vr-T Dx |
| Abbott Laboratories | $4,084.55 | 2020-2025 | Ensite Precision, Aveir, Ensite |
| Philips North America LLC | $3,689.75 | 2022 | |
| Boston Scientific Corporation | $2,870.73 | 2022-2025 | Farapulse, General - Therapies, Emblem Mri S-Icd |
| Pfizer INC. | $105.40 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.95 | 2023-2025 | Lifevest |
| Biosense Webster, INC. | $77.19 | 2025 | Carto 3 |
| Baylis Medical Company INC | $57.66 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.71 | 2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $36.47 | 2023 | Xarelto |
| Davol INC. | $32.15 | 2024 | Arista Ah Flexitip |
| Amgen INC. | $20.78 | 2025 | Repatha |
| Medtronic Vascular, INC. | $12.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Kolman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.